Veterans’ Prostate Cancer Bill Reintroduced in House August 3, 2021 FOR IMMEDIATE RELEASEMEDIA CONTACT:Colony Brown(202) 640-8265colony@zerocancer.org Veteran’s Prostate Cancer Bill Reintroduced in House (Washington, D.C. – August 2, 2021) This week, the Veteran’s Prostate Cancer Treatment and Research Act (H.R. 4880) was reintroduced on the House floor by Congressman Neal Dunn, M.D. (R-FL-02) and Congresswoman Elissa Slotkin (D-MI-08). ZERO Prostate Cancer, the leading national nonprofit in the fight against this disease, is proud to be an ongoing supporter of this bipartisan bill and its provisions to establish a national clinical pathway for prostate cancer within the Veterans Health Administration. “H.R. 4880 will help to ensure that Veterans from Tallahassee, FL, to Ft. Worth, TX, to Seattle, WA, have equal access to the best possible care – care that can make the difference in surviving prostate cancer,” said Alison Manson, ZERO’s Vice President of Advocacy and Government Relations.This standardized system of care would enhance treatment and increase access to the highest quality care for the most commonly diagnosed cancer in the Veterans Health Administration. Currently, no such national clinical pathway exists for prostate cancer. The bill was previously introduced in the House as H.R. 6092 by Congressman Dunn on March 5, 2020. The bill passed unopposed in the House on September 22nd, 2020, but ultimately failed in the Senate. Veterans face prostate cancer at rates nearly two times higher than civilians.For more information on ZERO’s work with veterans, visit zerocancer.org/veterans. About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org About Prostate Cancer Advocacy Press Release More for you
FOR IMMEDIATE RELEASEMEDIA CONTACT:Colony Brown(202) 640-8265colony@zerocancer.org Veteran’s Prostate Cancer Bill Reintroduced in House (Washington, D.C. – August 2, 2021) This week, the Veteran’s Prostate Cancer Treatment and Research Act (H.R. 4880) was reintroduced on the House floor by Congressman Neal Dunn, M.D. (R-FL-02) and Congresswoman Elissa Slotkin (D-MI-08). ZERO Prostate Cancer, the leading national nonprofit in the fight against this disease, is proud to be an ongoing supporter of this bipartisan bill and its provisions to establish a national clinical pathway for prostate cancer within the Veterans Health Administration. “H.R. 4880 will help to ensure that Veterans from Tallahassee, FL, to Ft. Worth, TX, to Seattle, WA, have equal access to the best possible care – care that can make the difference in surviving prostate cancer,” said Alison Manson, ZERO’s Vice President of Advocacy and Government Relations.This standardized system of care would enhance treatment and increase access to the highest quality care for the most commonly diagnosed cancer in the Veterans Health Administration. Currently, no such national clinical pathway exists for prostate cancer. The bill was previously introduced in the House as H.R. 6092 by Congressman Dunn on March 5, 2020. The bill passed unopposed in the House on September 22nd, 2020, but ultimately failed in the Senate. Veterans face prostate cancer at rates nearly two times higher than civilians.For more information on ZERO’s work with veterans, visit zerocancer.org/veterans.
About ZERO Prostate CancerZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care. As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease. Learn more at ZEROcancer.org
